V. Stoppino

Clarithromycin-Resistant Genotypes and Eradication of <i>Helicobacter pylori</i>

Vincenzo De Francesco, Angelo Zullo, Cesare Hassan et al. · Annals of Internal Medicine · 2006 · 197 citations

Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease - a double-blind, randomised, placebo-controlled study

Antonio Tursi, Giovanni Brandimarte, Walter Elisei et al. · Alimentary Pharmacology & Therapeutics · 2013 · 152 citations · Full text

Sequential treatment for <scp>Helicobacter pylori</scp> does not share the risk factors of triple therapy failure

Vincenzo De Francesco, Angelo Zullo, M. Margiotta et al. · Alimentary Pharmacology & Therapeutics · 2004 · 107 citations · Full text

The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study

Vincenzo De Francesco, Angelo Zullo, Cesare Hassan et al. · Digestive and Liver Disease · 2004 · 81 citations

Triple Therapy, Gastroenterology, Clinical Gastroenterology +3

Effectiveness and pharmaceutical cost of sequential treatment for <scp>Helicobacter pylori</scp> in patients with non‐ulcer dyspepsia

Vincenzo De Francesco, Nicola Della Valle, V. Stoppino et al. · Alimentary Pharmacology & Therapeutics · 2004 · 35 citations · Full text